| Entry |
|
|---|
| Name |
Tiletamine hydrochloride (USP) |
|---|
| Formula |
C12H17NOS. HCl
|
|---|
| Exact mass |
259.0798
|
|---|
| Mol weight |
259.80
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Anesthetic, Anticonvulsant |
|---|
| Comment |
Phencyclidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
DG01380 Tiletamine
D06146 Tiletamine hydrochloride
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D06146 Tiletamine hydrochloride (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
DG01380 Tiletamine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 16
1 C1x C 27.2312 -17.2214
2 C1x C 27.2312 -18.6215
3 C1x C 28.4437 -19.3216
4 C1x C 29.6563 -18.6215
5 C1z C 29.6563 -17.2214
6 C5x C 28.4437 -16.5214
7 C8y C 30.8875 -16.5104
8 C8x C 32.2128 -16.9230
9 C8x C 33.0170 -15.7893
10 C8x C 32.1875 -14.6742
11 S2x S 30.8705 -15.1186
12 N1b N 30.8688 -17.9215
13 C1b C 30.8389 -19.3211
14 C1a C 32.0601 -20.0616
15 O5x O 28.4437 -15.1215
16 X Cl 36.1219 -17.9215
BOND 16
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 7 11 1
13 5 12 1
14 12 13 1
15 13 14 1
16 6 15 2
|
|---|
